“ Adherence and Or Discontinuation of Imatinib Mesylate in Patients With Chronic Myeloid Leukemia ”. Brazilian Journal of Pharmaceutical Sciences 52, no. 4 (December 1, 2016): 581–589. Accessed June 10, 2024. https://periodicos.usp.br/bjps/article/view/128373.